MiniMed Group is trading at $20.97, up +6.44% pre-market, as Medtronic’s exchange-offer pricing begins; coverage found no fresh company-specific explanation.
- Pricing runs October 5–7; the final exchange ratio is expected before the offer expires October 9.
- The September 1 fiscal Q1 call reported $843 million in revenue and raised full-year organic revenue growth guidance to approximately 10.5%; it was not a new October 5 catalyst.
- Broader indexes were nearly flat, offering no clear market-wide explanation.